SPIRIVA (tiotropium bromide) – an anticholinergic inhaled product commonly used to treat bronchospasm in patients with chronic obstructive pulmonary disease. FDA approved uses: Spiriva is indicated for the long-term, once-daily, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), and for reducing COPD exacerbations. Available dosage forms: Capsules for oral inhalation. 18 mcg […]
OXYCONTIN (oxycodone) – an opioid agonist product commonly used to treat moderate to severe pain in patients requiring continuous around the clock opioid analgesia. FDA approved uses: Oxycontin is indicated for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. OxyContin is NOT […]
ATRIPLA (efavirenz/emtricitabine/tenofovir disoproxil fumarate) – a combination of 2 nucleoside analog HIV-1 reverse transcriptase inhibitors and 1 non-nucleoside HIV-1 reverse transcriptase inhibitor commonly used to treat infection by the human immunodeficiency virus (HIV). FDA approved uses: Atripla is indicated for use alone as a complete regimen or in combination with other antiretroviral agents to treat […]
RITUXAN (rituximab) – a CD20-directed cytolytic antibody indicated for the treatment of patients with rheumatoid arthritis, Granulamatosis, and certain types of leukemias and lymphomas. Rituxan binds specifically to the antigen CD20, a hydrophobic transmembrane protein that is located on pre-B and mature B lymphocytes. The antigen is expressed on 90% of B-cell non=Hodgkins lymphomas (NHL) […]